Literature DB >> 15185226

Posterior myotomy/myectomy for persistent stooling problems in Hirschsprung's disease.

Barbara E Wildhaber1, Mikko Pakarinen, Risto J Rintala, Arnold G Coran, Daniel H Teitelbaum.   

Abstract

BACKGROUND: Hirschsprung's disease (HD) patients after pull-through (PT) may have recalcitrant constipation or recurrent enterocolitis (EC). Posterior myotomy/myectomy (POMM) are possible options for these problems. This study analyzed the outcome of POMM in HD patients post-PT.
METHODS: Records of 348 HD patients were reviewed, and 32 were found to have undergone a POMM post-PT (1981 to 2002). Outcomes after this procedure were assessed. Statistics used linear and logistic regression.
RESULTS: Of the 32 patients, 29 had complete records for analysis. Of those with pure constipation (12), 6 had aganglionosis post-PT. Of those with recurrent EC (17) only 1 had aganglionosis post-PT. POMM was performed at a mean of 3.1 years post-PT (11 myotomy, 18 myectomy). Average follow-up was 8.6 years (range, 0.7 to 21). Type of POMM had no correlation with overall functional outcome (P =.44). Of those with chronic constipation, 60% had good results after POMM; the remainder required a redo-PT or colostomy. Interestingly, most patients with retained aganglionosis and chronic constipation did not respond after POMM (83%). Of those with recurrent EC, 75% became free of symptoms; none of the patients not responding have required redo-PT.
CONCLUSIONS: POMM to treat chronic constipation or recurrent EC in patients with HD post-PT is moderately successful. Because of the unsuccessful outcome with POMM in patients with a combination of constipation and aganglionosis, one should defer to a redo-PT in this group.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15185226     DOI: 10.1016/j.jpedsurg.2004.02.016

Source DB:  PubMed          Journal:  J Pediatr Surg        ISSN: 0022-3468            Impact factor:   2.545


  19 in total

Review 1.  New insights into the pathogenesis of Hirschsprung's associated enterocolitis.

Authors:  Feilim Murphy; Prem Puri
Journal:  Pediatr Surg Int       Date:  2005-09-30       Impact factor: 1.827

Review 2.  Transplanting the enteric nervous system: a step closer to treatment for aganglionosis.

Authors:  Michael D Gershon
Journal:  Gut       Date:  2007-04       Impact factor: 23.059

Review 3.  Hirschsprung-associated enterocolitis: pathogenesis, treatment and prevention.

Authors:  Farokh R Demehri; Ihab F Halaweish; Arnold G Coran; Daniel H Teitelbaum
Journal:  Pediatr Surg Int       Date:  2013-09       Impact factor: 1.827

Review 4.  Redo pullthrough for Hirschsprung disease.

Authors:  Matthew W Ralls; Arnold G Coran; Daniel H Teitelbaum
Journal:  Pediatr Surg Int       Date:  2016-12-31       Impact factor: 1.827

5.  Botox injection treatment for anal outlet obstruction in patients with internal anal sphincter achalasia and Hirschsprung's disease.

Authors:  A I Koivusalo; M P Pakarinen; R J Rintala
Journal:  Pediatr Surg Int       Date:  2009-10       Impact factor: 1.827

6.  Use of Clostridium botulinum toxin in gastrointestinal motility disorders in children.

Authors:  Ricardo A Arbizu; Leonel Rodriguez
Journal:  World J Gastrointest Endosc       Date:  2015-05-16

Review 7.  Guidelines for the management of postoperative soiling in children with Hirschsprung disease.

Authors:  P Saadai; A F Trappey; A M Goldstein; R A Cowles; L De La Torre; M M Durham; E Y Huang; M A Levitt; K Rialon; M Rollins; D H Rothstein; J C Langer
Journal:  Pediatr Surg Int       Date:  2019-06-14       Impact factor: 1.827

8.  Redo surgery with longitudinal resection for dilated bowel in Hirschsprung disease: an illustrative case series.

Authors:  Daniëlle Roorda; Tessa J Surridge; Ruben G J Visschers; Joep P M Derikx; L W Ernest van Heurn
Journal:  Int J Colorectal Dis       Date:  2019-10-19       Impact factor: 2.571

Review 9.  The developmental etiology and pathogenesis of Hirschsprung disease.

Authors:  Naomi E Butler Tjaden; Paul A Trainor
Journal:  Transl Res       Date:  2013-03-22       Impact factor: 7.012

Review 10.  Hirschsprung-associated enterocolitis: prevention and therapy.

Authors:  Philip K Frykman; Scott S Short
Journal:  Semin Pediatr Surg       Date:  2012-11       Impact factor: 2.754

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.